2m 2m 2m 2m 2m 2m 2m
GENMAB SP ADR (GMAB)
NASDAQ
$25.94+$0.33 (+1.29%)
Price as of Jun 23, 2026 4:37 PM EDT- $15.7BMarket Cap
- 23.84%1-Year Change
- BiotechnologyIndustry
GENMAB SP ADR (GMAB)
$25.94+$0.33 (+1.29%)
GMAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.61 | ||
Change | +$0.34 (+1.35%) | ||
Open | $25.05 | ||
High | $25.66 | ||
Low | $24.88 | ||
Previous Close | $25.27 | ||
Volume | 1,593,105 | ||
30-Day Average Volume | 1,649,995 | ||
1-Week Change | 4.19% | ||
1-Month Change | -4.69% | ||
1-Year Change | 23.84% | ||
3-Year Change | -33.45% | ||
5-Year Change | -40.85% | ||
Fundamentals | |||
Shares Outstanding | 613.9M | ||
Total Assets | $12.9B | ||
Market Cap | $15.7B | ||
Enterprise Value | $14.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue